Extracorporeal blood circulation requires heparin anticoagulation to provide blood compatibility. However, in acutely ill patients at high risk of bleeding, the use of heparin often leads to life-threatening hemorrhagic complications. To avoid such complications, protamine, a heparin antagonist, is generally administered at the conclusion of the extracorporeal procedure to counteract heparin's anticoagulant activity. Although protamine has been approved by FDA for such therapeutic use, it is nevertheless a relatively toxic compound. But as long as there are no alternatives to control the more serious bleeding problems, protamine remains in use in conjunction with heparin therapy despite its toxic effects. A method is suggested in this proposal which would potentially eliminate the bleeding risks associated with heparinization, and would at the same time minimize the toxic effects resulting from heparin neutralization with protamine. This approach consists of a blood filter containing immobilized protamine (i.e., a protamine filter) which could be placed at the termination of any extracorporeal device. The protamine filter would bind and selectively remove heparin before it returned to the patient from the extracorporeal circuit, and meanwhile, would maintain the protamine treatment at regions outside the patient's body, thereby minimizing protamine's toxic effects.
The specific aims of this proposal are: (i) to develop and construct a blood compatible protamine filter, (ii) to test the function of the filter in vitro, (iii) to evaluate the performance and hemocompatibility of the filter in vivo, and (iv) to examine the effectiveness of the proposed system in preventing heparin complications and protamine toxicities.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
First Independent Research Support & Transition (FIRST) Awards (R29)
Project #
5R29HL038353-05
Application #
3471144
Study Section
Surgery and Bioengineering Study Section (SB)
Project Start
1987-04-01
Project End
1993-03-31
Budget Start
1991-04-01
Budget End
1993-03-31
Support Year
5
Fiscal Year
1991
Total Cost
Indirect Cost
Name
University of Michigan Ann Arbor
Department
Type
Schools of Pharmacy
DUNS #
791277940
City
Ann Arbor
State
MI
Country
United States
Zip Code
48109
Ma, S C; Yang, V C; Meyerhoff, M E (1992) Heparin-responsive electrochemical sensor: a preliminary study. Anal Chem 64:694-7
Yang, V C; Fu, Y Y; Kim, J S (1991) Protamine-coated Cuprophan. A potential nonthrombogenic hemodialysis membrane with improved blood compatibility. ASAIO Trans 37:M229-32
Yang, V C; Port, F K; Kim, J S et al. (1991) The use of immobilized protamine in removing heparin and preventing protamine-induced complications during extracorporeal blood circulation. Anesthesiology 75:288-97
Yang, V C; Chen, W (1991) A protamine-mediated heparin sensing device. ASAIO Trans 37:M292-4
Yang, V C; Teng, C L; Kim, J S (1990) A filter device for the prevention of both heparin- and protamine-induced complications associated with extracorporeal therapy. Biomed Instrum Technol 24:433-9
Fu, Y Y; Teng, C L; Yang, V C (1990) Rapid and precise whole blood protamine titration. ASAIO Trans 36:M660-3
Tsuei, A C; Yang, V C (1990) Preparation of diethylaminoethyl hollow fibres for high-flow liquid chromatography. Biomaterials 11:734-7
Teng, C L; Yang, V C (1989) A facile colorimetric protamine titration method. J Lab Clin Med 113:498-504
Yang, V C (1989) A simple method for rapid and precise estimation of the protamine dose required for clinical heparin reversal. ASAIO Trans 35:274-7
Teng, C L; Kim, J S; Port, F K et al. (1988) A protamine filter for extracorporeal blood heparin removal. ASAIO Trans 34:743-6